These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 overexpressing cancer. Duwa R; Pokhrel RH; Banstola A; Pandit M; Shrestha P; Jeong JH; Chang JH; Yook S Biomaterials; 2022 Dec; 291():121911. PubMed ID: 36399833 [TBL] [Abstract][Full Text] [Related]
4. CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells. Wang YY; Zhang DD; Kong YY; Shao LL; Zhang FY; Gao Y; Mu X; Wang J; Li HF; Yu SQ; Xu Q Colloids Surf B Biointerfaces; 2016 Sep; 145():716-727. PubMed ID: 27289313 [TBL] [Abstract][Full Text] [Related]
6. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses. He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression. Zhao J; Zhang Z; Xue Y; Wang G; Cheng Y; Pan Y; Zhao S; Hou Y Theranostics; 2018; 8(22):6307-6321. PubMed ID: 30613299 [TBL] [Abstract][Full Text] [Related]
8. MnO Tang S; Zhou L; He H; Cui L; Ren Z; Tai Y; Xie Z; Cao Y; Meng D; Liu Q; Wu Y; Jiang J; Zhou X Biomaterials; 2022 Sep; 288():121706. PubMed ID: 35953328 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages. Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735 [TBL] [Abstract][Full Text] [Related]
10. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Tan S; Wang G Drug Des Devel Ther; 2017; 11():3519-3529. PubMed ID: 29263650 [TBL] [Abstract][Full Text] [Related]
11. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. Lee SY; Koo JS; Yang M; Cho HJ J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352 [TBL] [Abstract][Full Text] [Related]
12. Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model. Ramzy A; Soliman AH; Hassanein SI; Sebak AA Drug Deliv Transl Res; 2024 Feb; 14(2):491-509. PubMed ID: 37612575 [TBL] [Abstract][Full Text] [Related]
13. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8 Zhang X; Wei Z; Yong T; Li S; Bie N; Li J; Li X; Liu H; Xu H; Yan Y; Zhang B; Chen X; Yang X; Gan L Nat Commun; 2023 Sep; 14(1):5653. PubMed ID: 37704614 [TBL] [Abstract][Full Text] [Related]
14. Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor. Rajendrakumar SK; Mohapatra A; Singh B; Revuri V; Lee YK; Kim CS; Cho CS; Park IK Polymers (Basel); 2018 Sep; 10(10):. PubMed ID: 30960988 [TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of chitosan/polyacrylic acid/copper nanocomposites and their impact on onion production. Abd El-Aziz ME; Morsi SMM; Salama DM; Abdel-Aziz MS; Abd Elwahed MS; Shaaban EA; Youssef AM Int J Biol Macromol; 2019 Feb; 123():856-865. PubMed ID: 30452990 [TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses. Walter F; Winter E; Rahn S; Heidland J; Meier S; Struzek AM; Lettau M; Philipp LM; Beckinger S; Otto L; Möller JL; Helm O; Wesch D; Scherließ R; Sebens S PLoS One; 2020; 15(9):e0239369. PubMed ID: 32997691 [TBL] [Abstract][Full Text] [Related]
18. Chitosan coated pH-responsive metal-polyphenol delivery platform for melanoma chemotherapy. Mu M; Liang X; Chuan D; Zhao S; Yu W; Fan R; Tong A; Zhao N; Han B; Guo G Carbohydr Polym; 2021 Jul; 264():118000. PubMed ID: 33910734 [TBL] [Abstract][Full Text] [Related]
19. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors. Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT Front Immunol; 2023; 14():1334800. PubMed ID: 38259462 [TBL] [Abstract][Full Text] [Related]
20. Facile fabrication of poly(acrylic acid) coated chitosan nanoparticles with improved stability in biological environments. Wu Y; Wu J; Cao J; Zhang Y; Xu Z; Qin X; Wang W; Yuan Z Eur J Pharm Biopharm; 2017 Mar; 112():148-154. PubMed ID: 27890571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]